Botanical Name: 
							Pleurotus ostreatus, 
								P. sapidus, P. pulmonarius, 
								P. citrino-pileatus, and many more
					Preparation and Serving Suggestions: 
								Rinse or brush lightly. Sauté or stir fry in oil or butter. Great in pasta dishes, meat dishes, omelets, and soups. 
				 | 
				 | 
			
			
				Description: 
							Oyster mushrooms comprise a long list of different Pleurotus species and are available in an amazing array of colors and sizes. They have a texture much like their seafood namesake, with a mild pleasant taste.
					Reported Health Benefits: 
								Oyster mushrooms are best known medically for their cardiovascular and cholesterol-controlling benefits. Oyster mushrooms contain mevinolin and related compounds which are potent competitive inhibitors of HMG CoA reductase (3-hydroxy-3-methyl-glutaryl coenzyme A reductuctase), the major rate limiting enzyme in cholesterol biosynthesis. In addition, they have been shown to have activity in the following: 
								* Antitumor 
								* Immune response 
								* Anti-inflammatory 
								* Antiviral 
								* Antibiotic 
					Selected References: 
								Actual Reviews for Selected Medicinal Properties of Mushrooms. Cholesterol-Lowering Effect of Pleurotus Species (Agaricomycetideae) (Abstracts of papers published in 1991-1999). 1999. Int J of Med Mushrooms. Vol. 1(4) :371-380 
								 
								Arigoni,. A. 1982. Studies on terpene biosynthesis; production of the antibiotic pleurotin. Abstr Pap m Chem Soc, 184 Meet. 
								 
								Babitskatya, V.G., et al. 1999. Some Biologically Active Substances from Medicinal Mushroom Pleurotus ostreatus (Jacq.:Fr.)P.Kumm.(Agaricomycetideae). Int J of Med Mushrooms. Vol. 1(4) :345-349 
								 
								Bajaj, M., et al. 1997. Role of oyster mushroom (Pleurotus florida) as hypocholesterolemic-antiatherogenic agent. J Exper Biol, 35(10), 1070-1075 
								 
								Bobek, P., et al, 1991. Cholesterol lowering effect of the mushroom Pleurotus ostreatus in hereditary hypercholesterolemic rats. Ann Nutr Metab 35(4):191-195 
								 
								Bobek, P., et al. 1998. Dose and time dependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Nutrition 14(3):282-286 
								 
								Gunde-Cimerman,. N. 1999. Medicinal value of the genus Pleurotus (Fr.) P. Darst. (Agaricales s.l., Basidiomycetes). Int J of Med Mushrooms. Vol. 1(1):69-80 
								 
								Guzman, G.. 2000. Genus Pleurotus (Jacq.:Fr.) P. Kumm. (Agaricomycetideae): Diversity, Taxonomic Problems, and Cultural and Traditional Medicinal Uses. Int J of Med Mushrooms. Vol. 2(2) :95-123 
								 
								Gunde-Cimerman, N., and Plemenitas, A. 2001. Hyporcholesterolemic Activity of the Genus Pleurotus (Fr.) Karst. (Agaricales s.l., Basidiomycetes). Perspectives of Medicinal Mushrooms in Healthcare and Nutrition in the 21st Century. 12-14 Septemeber Kiev, Ukraine. Abstract in International Journal of Medicinal Mushrooms 3(2-3). Pg. 91. 
								 
								Kurashige, S., et al. 1997. Effects Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl N-butanolnitrosamine. Immunopharmacol Immunotoxicol, 19(2), 175-183 
								 
								Noda-Shokkin. 1998. A preparation for kidney treatment possessing antiinflammatory activity, obtained from Basidomycetes, e.g. Lentinus, Pleurotus, Flammulina,and Tricholoma. Patent JPJ 61171428 (1986) JP 85-11888 (1985) 
								 
								Wasser, S. P. and A. L. Weis. 1999. Medicinal properties of substances occurring in higher basidiomycetes mushrooms. Int J of Med Mushrooms.Vol. 1(1):31-62 
				 | 
				 |